{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:07Z","timestamp":1790878207508,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160690"],"award-info":[{"award-number":["82160690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004001","name":"Science and Technology Foundation of Guizhou Province","doi-asserted-by":"crossref","award":["ZK[2021]-014"],"award-info":[{"award-number":["ZK[2021]-014"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Collaborative Innovation Center of Chinese Ministry of Education","award":["2020-39"],"award-info":[{"award-number":["2020-39"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD), a neurodegenerative disorder with an unknown etiology, is primarily characterized by the degeneration of dopamine (DA) neurons. The prevalence of PD has experienced a significant surge in recent years. The unidentified etiology poses limitations to the development of effective therapeutic interventions for this condition.\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    (\n                    <jats:italic>H. pylori<\/jats:italic>\n                    ) infection has affected approximately half of the global population. Mounting evidences suggest that\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection plays an important role in PD through various mechanisms. The autotoxin produced by\n                    <jats:italic>H. pylori<\/jats:italic>\n                    induces pro-inflammatory cytokines release, thereby facilitating the occurrence of central inflammation that leads to neuronal damage. Simultaneously,\n                    <jats:italic>H. pylori<\/jats:italic>\n                    disrupts the equilibrium of gastrointestinal microbiota with an overgrowth of bacteria in the small intestinal known as small intestinal bacterial overgrowth (SIBO). This dysbiosis of the gut flora influences the central nervous system (CNS) through microbiome-gut-brain axis. Moreover, SIBO hampers levodopa absorption and affects its therapeutic efficacy in the treatment of PD. Also,\n                    <jats:italic>H. pylori<\/jats:italic>\n                    promotes the production of defensins to regulate the permeability of the blood-brain barrier, facilitating the entry of harmful factors into the CNS. In addition,\n                    <jats:italic>H. pylori<\/jats:italic>\n                    has been found to induce gastroparesis, resulting in a prolonged transit time for levodopa to reach the small intestine.\n                    <jats:italic>H. pylori<\/jats:italic>\n                    may exploit levodopa to facilitate its own growth and proliferation, or it can inflict damage to the gastrointestinal mucosa, leading to gastrointestinal ulcers and impeding levodopa absorption. Here, this review focused on the role of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    infection in PD from etiology, pathogenesis to levodopa bioavailability.\n                  <\/jats:p>","DOI":"10.1186\/s12979-023-00404-1","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T01:02:37Z","timestamp":1704157357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Helicobacter pylori infection and Parkinson\u2019s Disease: etiology, pathogenesis and levodopa bioavailability"],"prefix":"10.1186","volume":"21","author":[{"given":"Bang-rong","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"404_CR1","doi-asserted-by":"publisher","first-page":"104842","DOI":"10.1016\/j.archger.2022.104842","volume":"104","author":"P Lampela","year":"2023","unstructured":"Lampela P, Tolppanen AM, Kaarniranta K, Hokkinen K, Hartikainen S. Incidence of cataract surgeries in relation to diagnosis of Parkinson\u2019s Disease. Arch Gerontol Geriatr. 2023;104:104842.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"404_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41536-022-00221-y","volume":"7","author":"BM Hiller","year":"2022","unstructured":"Hiller BM, Marmion DJ, Thompson CA, Elliott NA, Federoff H, Brundin P, et al. Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson\u2019s Disease. NPJ Regen Med. 2022;7(1):24.","journal-title":"NPJ Regen Med"},{"issue":"100","key":"404_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and Parkinson\u2019s Disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14(100):19\u201330.","journal-title":"Ageing Res Rev"},{"key":"404_CR4","doi-asserted-by":"publisher","first-page":"134516","DOI":"10.1016\/j.neulet.2019.134516","volume":"712","author":"S Sharma","year":"2019","unstructured":"Sharma S, Awasthi A, Singh S. Altered gut microbiota and intestinal permeability in Parkinson\u2019s Disease: pathological highlight to management. Neurosci Lett. 2019;712:134516.","journal-title":"Neurosci Lett"},{"key":"404_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2017.02.029","volume":"39","author":"A Su","year":"2017","unstructured":"Su A, Gandhy R, Barlow C, Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson\u2019s Disease. Parkinsonism Relat Disord. 2017;39:17\u201326.","journal-title":"Parkinsonism Relat Disord"},{"key":"404_CR6","doi-asserted-by":"publisher","first-page":"619354","DOI":"10.3389\/fcimb.2021.619354","volume":"11","author":"ZJ Chen","year":"2021","unstructured":"Chen ZJ, Liang CY, Yang LQ, Ren SM, Xia YM, Cui L, et al. Association of Parkinson\u2019s Disease with microbes and microbiological therapy. Front Cell Infect Microbiol. 2021;11:619354.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"404_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ijms24010042","volume":"24","author":"M Bisaglia","year":"2022","unstructured":"Bisaglia M. Mediterranean diet and Parkinson\u2019s Disease. Int J Mol Sci. 2022;24(1):42.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"404_CR8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/cns.13916","volume":"28","author":"HX Fan","year":"2022","unstructured":"Fan HX, Sheng S, Zhang F. New hope for Parkinson\u2019s Disease treatment: targeting gut microbiota. CNS Neurosci Ther. 2022;28(11):1675\u201388.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"404_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/etm.2021.10517","volume":"22","author":"IF Ivan","year":"2021","unstructured":"Ivan IF, Irincu VL, Diaconu \u0218, Falup-Pecurariu O, Ciopleia\u0219 B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson\u2019s Disease (review). Exp Ther Med. 2021;22(4):1083.","journal-title":"Exp Ther Med"},{"issue":"8","key":"404_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s Disease. Mov Disord. 2018;33(8):1248\u201366.","journal-title":"Mov Disord"},{"key":"404_CR11","doi-asserted-by":"publisher","first-page":"923477","DOI":"10.3389\/fimmu.2022.923477","volume":"13","author":"R Deng","year":"2022","unstructured":"Deng R, Zheng H, Cai H, Li M, Shi Y, Ding S. Effects of helicobacter pylori on Tumor microenvironment and immunotherapy responses. Front Immunol. 2022;13:923477.","journal-title":"Front Immunol"},{"key":"404_CR12","doi-asserted-by":"publisher","first-page":"868225","DOI":"10.3389\/fimmu.2022.868225","volume":"13","author":"D Sijmons","year":"2022","unstructured":"Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the role of lipopolysaccharide variation in innate immune evasion. Front Immunol. 2022;13:868225.","journal-title":"Front Immunol"},{"issue":"9","key":"404_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3390\/cells10092191","volume":"10","author":"J Baj","year":"2021","unstructured":"Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, et al. Helicobacter pylori Infection and extragastric diseases-A focus on the central nervous system. Cells. 2021;10(9):2191.","journal-title":"Cells"},{"issue":"6","key":"404_CR14","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1111\/j.1468-1331.2012.03695.x","volume":"19","author":"J Kountouras","year":"2012","unstructured":"Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E, et al. Helicobacter pylori Infection and Parkinson\u2019s Disease: apoptosis as an underlying common contributor. Eur J Neurol. 2012;19(6):e56.","journal-title":"Eur J Neurol"},{"key":"404_CR15","doi-asserted-by":"publisher","first-page":"584165","DOI":"10.3389\/fimmu.2020.584165","volume":"11","author":"N Gorl\u00e9","year":"2020","unstructured":"Gorl\u00e9 N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE. Helicobacter and the potential role in neurological disorders: there is more than Helicobacter pylori. Front Immunol. 2020;11:584165.","journal-title":"Front Immunol"},{"issue":"10","key":"404_CR16","doi-asserted-by":"publisher","first-page":"e1006573","DOI":"10.1371\/journal.ppat.1006573","volume":"13","author":"JM Noto","year":"2017","unstructured":"Noto JM, Peek RM Jr. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to Stomach cancer. PLoS Pathog. 2017;13(10):e1006573.","journal-title":"PLoS Pathog"},{"issue":"1","key":"404_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JPD-212929","volume":"12","author":"S Shen","year":"2022","unstructured":"Shen S, Zhang C, Xu YM, Shi CH. The role of pathogens and anti-infective agents in Parkinson\u2019s Disease, from etiology to therapeutic implications. J Parkinsons Dis. 2022;12(1):27\u201344.","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"404_CR18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00415-020-09723-5","volume":"267","author":"M Lubomski","year":"2020","unstructured":"Lubomski M, Davis RL, Sue CM. Gastrointestinal dysfunction in Parkinson\u2019s Disease. J Neurol. 2020;267(5):1377\u201388.","journal-title":"J Neurol"},{"issue":"1","key":"404_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","volume":"29","author":"Z Li","year":"2023","unstructured":"Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y, et al. Gut bacterial profiles in Parkinson\u2019s Disease: a systematic review. CNS Neurosci Ther. 2023;29(1):140\u201357.","journal-title":"CNS Neurosci Ther"},{"key":"404_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphys.2011.00094","volume":"2","author":"S Grenham","year":"2011","unstructured":"Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and Disease. Front Physiol. 2011;2:94.","journal-title":"Front Physiol"},{"issue":"37","key":"404_CR21","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson\u2019s Disease. World J Gastroenterol. 2015;21(37):10609\u201320.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"404_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","volume":"17","author":"RA Travagli","year":"2020","unstructured":"Travagli RA, Browning KN, Camilleri M. Parkinson Disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2020;17(11):673\u201385.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"404_CR23","doi-asserted-by":"publisher","first-page":"878239","DOI":"10.3389\/fnins.2022.878239","volume":"16","author":"X Sun","year":"2022","unstructured":"Sun X, Xue L, Wang Z, Xie A. Update to the treatment of Parkinson\u2019s Disease based on the gut-brain axis mechanism. Front Neurosci. 2022;16:878239.","journal-title":"Front Neurosci"},{"issue":"2","key":"404_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s Disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"404_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805\u201320.","journal-title":"Acta Neuropathol"},{"key":"404_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fnmol.2019.00218","volume":"12","author":"QQ Chen","year":"2019","unstructured":"Chen QQ, Haikal C, Li W, Li JY. Gut inflammation in association with pathogenesis of Parkinson\u2019s Disease. Front Mol Neurosci. 2019;12:218.","journal-title":"Front Mol Neurosci"},{"issue":"s1","key":"404_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-223271","volume":"12","author":"KM Shannon","year":"2022","unstructured":"Shannon KM. Infections and changes in commensal bacteria and the pathogenesis of Parkinson\u2019s Disease. J Parkinsons Dis. 2022;12(s1):45\u2013S51.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"404_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.34172\/mejdd.2022.261","volume":"14","author":"SA Shamsdin","year":"2022","unstructured":"Shamsdin SA, Khazraei H, Rahimi Jaberi A, Zamani M, Rafiee Monjezi M. Evaluation of inflammatory cytokine and anti Helicobacter pylori antibodies in the pathogenesis of Parkinson\u2019s Disease. Middle East J Dig Dis. 2022;14(1):96\u2013102.","journal-title":"Middle East J Dig Dis"},{"issue":"1","key":"404_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1757-4749-4-12","volume":"4","author":"RJ Dobbs","year":"2012","unstructured":"Dobbs RJ, Charlett A, Dobbs SM, Weller C, MA AI, Iguodala O, et al. Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study. Gut Pathog. 2012;4(1):12.","journal-title":"Gut Pathog"},{"issue":"12","key":"404_CR30","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1007\/s00415-013-7089-6","volume":"260","author":"KE Rahne","year":"2013","unstructured":"Rahne KE, Tagesson C, Nyholm D. Motor fluctuations and Helicobacter pylori in Parkinson\u2019s Disease. J Neurol. 2013;260(12):2974\u201380.","journal-title":"J Neurol"},{"issue":"11","key":"404_CR31","doi-asserted-by":"publisher","first-page":"e112330","DOI":"10.1371\/journal.pone.0112330","volume":"9","author":"H Hashim","year":"2014","unstructured":"Hashim H, Azmin S, Razlan H, Yahya NW, Tan HJ, Manaf MR, et al. Eradication of Helicobacter pylori Infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson\u2019s Disease. PLoS ONE. 2014;9(11):e112330.","journal-title":"PLoS ONE"},{"issue":"3","key":"404_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","volume":"21","author":"AH Tan","year":"2015","unstructured":"Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, et al. Helicobacter pylori Infection is associated with worse severity of Parkinson\u2019s Disease. Parkinsonism Relat Disord. 2015;21(3):221\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"404_CR33","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1038\/s41598-017-07801-9","volume":"7","author":"G Efthymiou","year":"2017","unstructured":"Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, et al. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary Progressive multiple sclerosis. Sci Rep. 2017;7(1):7929.","journal-title":"Sci Rep"},{"key":"404_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clineuro.2017.07.003","volume":"160","author":"H Liu","year":"2017","unstructured":"Liu H, Su W, Li S, Du W, Ma X, Jin Y, et al. Eradication of Helicobacter pylori Infection might improve clinical status of patients with Parkinson\u2019s Disease, especially on bradykinesia. Clin Neurol Neurosurg. 2017;160:101\u20134.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"404_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3988\/jcn.2017.13.2.181","volume":"13","author":"KR Mridula","year":"2017","unstructured":"Mridula KR, Borgohain R, Chandrasekhar Reddy V, Bandaru V, Suryaprabha T. Association of Helicobacter pylori with Parkinson\u2019s Disease. J Clin Neurol. 2017;13(2):181\u20136.","journal-title":"J Clin Neurol"},{"key":"404_CR36","first-page":"OC05","volume":"12","author":"T Roshan","year":"2018","unstructured":"Roshan T, Bijani A, Hosseini SR, Bagherzade M, Saadat P, Zamani M. The association between Helicobacter pylori Infection and Parkinson\u2019s Disease: a case-control study. J Clin Diagn Res. 2018;12:OC05\u20138.","journal-title":"J Clin Diagn Res"},{"key":"404_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.31086\/tjgeri.2019.110","volume":"22","author":"S G\u00f6rg\u00fcn","year":"2019","unstructured":"G\u00f6rg\u00fcn S, Y\u0131lmaz A, \u00d6Zgan E, \u00c7al\u0131k M. Helicobacter pylori Infection is an avoidable risk factor for Parkinson s Disease. Turk J Geriatr. 2019;22:340\u20135.","journal-title":"Turk J Geriatr"},{"issue":"12","key":"404_CR38","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/mds.28248","volume":"35","author":"AH Tan","year":"2020","unstructured":"Tan AH, Lim SY, Mahadeva S, Loke MF, Tan JY, Ang BH, et al. Helicobacter pylori eradication in Parkinson\u2019s Disease: a randomized placebo-controlled trial. Mov Disord. 2020;35(12):2250\u201360.","journal-title":"Mov Disord"},{"issue":"5","key":"404_CR39","doi-asserted-by":"publisher","first-page":"e0251042","DOI":"10.1371\/journal.pone.0251042","volume":"16","author":"P Lolekha","year":"2021","unstructured":"Lolekha P, Sriphanom T, Vilaichone RK. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson\u2019s Disease patients: a prospective cohort study (HP-PD trial). PLoS ONE. 2021;16(5):e0251042.","journal-title":"PLoS ONE"},{"issue":"2","key":"404_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","volume":"12","author":"G \u00c7amc\u0131","year":"2016","unstructured":"\u00c7amc\u0131 G, O\u011fuz S. Association between Parkinson\u2019s Disease and Helicobacter pylori. J Clin Neurol. 2016;12(2):147\u201350.","journal-title":"J Clin Neurol"},{"issue":"4","key":"404_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbrc.2016.06.137","volume":"477","author":"CK Yu","year":"2016","unstructured":"Yu CK, Wang CJ, Chew Y, Wang PC, Yin HS, Kao MC. Functional characterization of Helicobacter pylori 26695 sedoheptulose 7-phosphate isomerase encoded by hp0857 and its association with lipopolysaccharide biosynthesis and adhesion. Biochem Biophys Res Commun. 2016;477(4):794\u2013800.","journal-title":"Biochem Biophys Res Commun"},{"key":"404_CR42","doi-asserted-by":"crossref","unstructured":"Beier EE, Neal M, Alam G, Edler M, Wu LJ, Richardson JR. Alternative microglial activation is associated with cessation of Progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis. 2017;108:115\u201327.","DOI":"10.1016\/j.nbd.2017.08.009"},{"key":"404_CR43","doi-asserted-by":"crossref","unstructured":"Park AM, Tsunoda I. Helicobacter pylori infection in the stomach induces neuroinflammation: the potential roles of bacterial outer membrane vesicles in an animal model of Alzheimer\u2019s disease. Inflamm Regen. 2022;42(1):39.","DOI":"10.1186\/s41232-022-00224-8"},{"issue":"10","key":"404_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/cns.13906","volume":"28","author":"QY Yang","year":"2022","unstructured":"Yang QY, Li XW, Yang R, Qin TY, Long H, Zhang SB, et al. Effects of intraperitoneal injection of lipopolysaccharide-induced peripheral inflammation on dopamine neuron damage in rat midbrain. CNS Neurosci Ther. 2022;28(10):1624\u201336.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"404_CR45","doi-asserted-by":"publisher","first-page":"e0172914","DOI":"10.1371\/journal.pone.0172914","volume":"12","author":"F Alhasson","year":"2017","unstructured":"Alhasson F, Das S, Seth R, Dattaroy D, Chandrashekaran V, Ryan CN, et al. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation. PLoS ONE. 2017;12(3):e0172914.","journal-title":"PLoS ONE"},{"issue":"5","key":"404_CR46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s Disease: a translational study from men to mice. Gut. 2019;68(5):829\u201343.","journal-title":"Gut"},{"issue":"5","key":"404_CR47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson\u2019s Disease. J Cereb Blood Flow Metab. 2015;35(5):747\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"key":"404_CR48","doi-asserted-by":"publisher","first-page":"104843","DOI":"10.1016\/j.psyneuen.2020.104843","volume":"121","author":"LK Figueroa-Hall","year":"2020","unstructured":"Figueroa-Hall LK, Paulus MP, Savitz J. Toll-like receptor signaling in depression. Psychoneuroendocrinology. 2020;121:104843.","journal-title":"Psychoneuroendocrinology"},{"issue":"16","key":"404_CR49","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1046\/j.1432-1327.2001.02385.x","volume":"268","author":"T Muta","year":"2001","unstructured":"Muta T, Takeshige K. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur J Biochem. 2001;268(16):4580\u20139.","journal-title":"Eur J Biochem"},{"issue":"6","key":"404_CR50","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ijo.2016.32","volume":"40","author":"R Pahwa","year":"2016","unstructured":"Pahwa R, Devaraj S, Jialal I. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on toll-like receptor 4 activity in human monocytes and adipocytes. Int J Obes. 2016;40(6):907\u201311.","journal-title":"Int J Obes"},{"issue":"11","key":"404_CR51","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.micinf.2004.05.010","volume":"6","author":"C Moreno","year":"2004","unstructured":"Moreno C, Merino J, Ram\u00edrez N, Echeverr\u00eda A, Pastor F, S\u00e1nchez-Ibarrola A. Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14. Microbes Infect. 2004;6(11):990\u20135.","journal-title":"Microbes Infect"},{"key":"404_CR52","doi-asserted-by":"crossref","unstructured":"Smith SM, Freeley M, Moynagh PN, Kelleher DP. Differential modulation of Helicobacter pylori lipopolysaccharide-mediated TLR2 signaling by individual pellino proteins. Helicobacter 2017; 22(1).","DOI":"10.1111\/hel.12325"},{"issue":"3","key":"404_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, et al. Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia. 2013;61(3):349\u201360.","journal-title":"Glia"},{"issue":"1","key":"404_CR54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s Disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):226.","journal-title":"Microbiome"},{"issue":"10","key":"404_CR55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neurol.2017.12.003","volume":"174","author":"A Alexoudi","year":"2018","unstructured":"Alexoudi A, Alexoudi I, Gatzonis S. Parkinson\u2019s Disease pathogenesis, evolution and alternative pathways: a review. Rev Neurol. 2018;174(10):699\u2013704.","journal-title":"Rev Neurol"},{"issue":"25","key":"404_CR56","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.3748\/wjg.v22.i25.5742","volume":"22","author":"A Mukherjee","year":"2016","unstructured":"Mukherjee A, Biswas A, Das SK. Gut dysfunction in Parkinson\u2019s Disease. World J Gastroenterol. 2016;22(25):5742\u201352.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"404_CR57","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-2836(03)00520-5","volume":"329","author":"R Bussell Jr","year":"2003","unstructured":"Bussell R Jr., Eliezer D. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol. 2003;329(4):763\u201378.","journal-title":"J Mol Biol"},{"issue":"5","key":"404_CR58","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/acschemneuro.8b00733","volume":"10","author":"D Bhattacharyya","year":"2019","unstructured":"Bhattacharyya D, Mohite GM, Krishnamoorthy J, Gayen N, Mehra S, Navalkar A, et al. Lipopolysaccharide from gut microbiota modulates \u03b1-synuclein aggregation and alters its biological function. ACS Chem Neurosci. 2019;10(5):2229\u201336.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"404_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-017-0452-6","volume":"5","author":"S Arawaka","year":"2017","unstructured":"Arawaka S, Sato H, Sasaki A, Koyama S, Kato T. Mechanisms underlying extensive Ser129-phosphorylation in \u03b1-synuclein aggregates. Acta Neuropathol Commun. 2017;5(1):48.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"404_CR60","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acschemneuro.8b00288","volume":"10","author":"Y He","year":"2019","unstructured":"He Y, Yu Z, Chen S. Alpha-synuclein nitration and its implications in Parkinson\u2019s Disease. ACS Chem Neurosci. 2019;10(2):777\u201382.","journal-title":"ACS Chem Neurosci"},{"key":"404_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tox.2013.01.006","volume":"305","author":"B Xu","year":"2013","unstructured":"Xu B, Wu SW, Lu CW, Deng Y, Liu W, Wei YG, et al. Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures. Toxicology. 2013;305:71\u20138.","journal-title":"Toxicology"},{"issue":"7","key":"404_CR62","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","volume":"62","author":"LM Collins","year":"2012","unstructured":"Collins LM, Toulouse A, Connor TJ, Nolan YM. Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s Disease. Neuropharmacology. 2012;62(7):2154\u201368.","journal-title":"Neuropharmacology"},{"issue":"4","key":"404_CR63","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","volume":"70","author":"L Wang","year":"2022","unstructured":"Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, et al. Lactobacillus plantarum DP189 reduces \u03b1-SYN aggravation in MPTP-induced Parkinson\u2019s Disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agric Food Chem. 2022;70(4):1163\u201373.","journal-title":"J Agric Food Chem"},{"issue":"5","key":"404_CR64","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1472-8206.2008.00616.x","volume":"22","author":"G Dutta","year":"2008","unstructured":"Dutta G, Zhang P, Liu B. The lipopolysaccharide Parkinson\u2019s Disease animal model: mechanistic studies and drug discovery. Fundam Clin Pharmacol. 2008;22(5):453\u201364.","journal-title":"Fundam Clin Pharmacol"},{"key":"404_CR65","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1749-6632.2002.tb04077.x","volume":"962","author":"B Liu","year":"2002","unstructured":"Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci. 2002;962:318\u201331.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"404_CR66","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/cns.14180","volume":"29","author":"JY He","year":"2023","unstructured":"He JY, Li DD, Wen Q, Qin TY, Long H, Zhang SB, et al. Synergistic effects of lipopolysaccharide and rotenone on dopamine neuronal damage in rats. CNS Neurosci Ther. 2023;29(8):2281\u201391.","journal-title":"CNS Neurosci Ther"},{"issue":"28","key":"404_CR67","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.0502552102","volume":"102","author":"J Li","year":"2005","unstructured":"Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A. 2005;102(28):9936\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"404_CR68","doi-asserted-by":"publisher","first-page":"30188","DOI":"10.1074\/jbc.M102061200","volume":"276","author":"S Sanlioglu","year":"2001","unstructured":"Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr., et al. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates Tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem. 2001;276(32):30188\u201398.","journal-title":"J Biol Chem"},{"issue":"2","key":"404_CR69","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0006-8993(89)90078-4","volume":"491","author":"M Sawada","year":"1989","unstructured":"Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of Tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 1989;491(2):394\u20137.","journal-title":"Brain Res"},{"issue":"2\u20134","key":"404_CR70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jnr.490210230","volume":"21","author":"E Hetier","year":"1988","unstructured":"Hetier E, Ayala J, Den\u00e8fle P, Bousseau A, Rouget P, Mallat M, et al. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res. 1988;21(2\u20134):391\u20137.","journal-title":"J Neurosci Res"},{"issue":"2","key":"404_CR71","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0014-5793(99)01348-4","volume":"460","author":"F Tombola","year":"1999","unstructured":"Tombola F, Oregna F, Brutsche S, Szab\u00f2 I, Del Giudice G, Rappuoli R, et al. Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori. FEBS Lett. 1999;460(2):221\u20135.","journal-title":"FEBS Lett"},{"issue":"4","key":"404_CR72","first-page":"620081","volume":"7","author":"PT Ly","year":"2008","unstructured":"Ly PT, Pelech S, Shaw CA. Cholesteryl glucoside stimulates activation of protein kinase B\/Akt in the motor neuron-derived NSC34 cell line. Neurobiol Lipids. 2008;7(4):620081.","journal-title":"Neurobiol Lipids"},{"issue":"1","key":"404_CR73","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1080\/21505594.2021.1969171","volume":"12","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Yeh JY, Chen CY, Wu HY, Chiang MH, Wu CL, et al. Helicobacter pylori cholesterol-\u03b1-glucosyltransferase manipulates cholesterol for bacterial adherence to gastric epithelial cells. Virulence. 2021;12(1):2341\u201351.","journal-title":"Virulence"},{"key":"404_CR74","doi-asserted-by":"crossref","unstructured":"Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An overview of Helicobacter pylori VacA toxin biology. Toxins 2016; 8(6).","DOI":"10.3390\/toxins8060173"},{"issue":"1","key":"404_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1379\/1466-1268(2000)005<0003:EOCGBH>2.0.CO;2","volume":"5","author":"S Kunimoto","year":"2000","unstructured":"Kunimoto S, Kobayashi T, Kobayashi S, Murakami-Murofushi K. Expression of cholesteryl glucoside by heat shock in human fibroblasts. Cell Stress Chaperones. 2000;5(1):3\u20137.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"404_CR76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1006\/excr.1999.4690","volume":"253","author":"ES Kandel","year":"1999","unstructured":"Kandel ES, Hay N. The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB. Exp Cell Res. 1999;253(1):210\u201329.","journal-title":"Exp Cell Res"},{"issue":"28","key":"404_CR77","doi-asserted-by":"publisher","first-page":"26357","DOI":"10.1074\/jbc.M011136200","volume":"276","author":"H Han","year":"2001","unstructured":"Han H, Wang H, Long H, Nattel S, Wang Z. Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem. 2001;276(28):26357\u201364.","journal-title":"J Biol Chem"},{"issue":"25","key":"404_CR78","doi-asserted-by":"publisher","first-page":"22368","DOI":"10.1074\/jbc.M011688200","volume":"276","author":"M Alvarez-Tejado","year":"2001","unstructured":"Alvarez-Tejado M, Naranjo-Suarez S, Jim\u00e9nez C, Carrera AC, Land\u00e1zuri MO, del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase\/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem. 2001;276(25):22368\u201374.","journal-title":"J Biol Chem"},{"issue":"9","key":"404_CR79","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/infdis\/jir547","volume":"204","author":"M Beigier-Bompadre","year":"2011","unstructured":"Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y. Modulation of the CD4\u2009+\u2009T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol \u03b1-glucoside content. J Infect Dis. 2011;204(9):1339\u201348.","journal-title":"J Infect Dis"},{"issue":"37","key":"404_CR80","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.3748\/wjg.v25.i37.5578","volume":"25","author":"BB de Brito","year":"2019","unstructured":"de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric Infection. World J Gastroenterol. 2019;25(37):5578\u201389.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"404_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/21505594.2020.1869441","volume":"12","author":"R Chatterjee","year":"2021","unstructured":"Chatterjee R, Chowdhury AR, Mukherjee D, Chakravortty D. Lipid Larceny: channelizing host lipids for establishing successful pathogenesis by bacteria. Virulence. 2021;12(1):195\u2013216.","journal-title":"Virulence"},{"issue":"27","key":"404_CR82","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.1073\/pnas.0502529102","volume":"102","author":"K Yokoyama","year":"2005","unstructured":"Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, et al. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A. 2005;102(27):9661\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"404_CR83","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/toxins2010069","volume":"2","author":"S Backert","year":"2010","unstructured":"Backert S, Tegtmeyer N. The versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk. Toxins. 2010;2(1):69\u201392.","journal-title":"Toxins"},{"issue":"5","key":"404_CR84","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1073\/pnas.96.5.2001","volume":"96","author":"DM Czajkowsky","year":"1999","unstructured":"Czajkowsky DM, Iwamoto H, Cover TL, Shao Z. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad Sci U S A. 1999;96(5):2001\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"404_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2958.2011.07910.x","volume":"83","author":"HJ Wang","year":"2012","unstructured":"Wang HJ, Cheng WC, Cheng HH, Lai CH, Wang WC. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during Infection in AGS cells. Mol Microbiol. 2012;83(1):67\u201384.","journal-title":"Mol Microbiol"},{"issue":"3","key":"404_CR86","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S0006-3495(99)77301-7","volume":"76","author":"F Tombola","year":"1999","unstructured":"Tombola F, Carlesso C, Szab\u00f2 I, de Bernard M, Reyrat JM, Telford JL, et al. Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys J. 1999;76(3):1401\u20139.","journal-title":"Biophys J"},{"issue":"1\u20132","key":"404_CR87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0014-5793(99)00474-3","volume":"450","author":"H Iwamoto","year":"1999","unstructured":"Iwamoto H, Czajkowsky DM, Cover TL, Szabo G, Shao Z. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett. 1999;450(1\u20132):101\u20134.","journal-title":"FEBS Lett"},{"issue":"20","key":"404_CR88","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1093\/emboj\/18.20.5517","volume":"18","author":"I Szab\u00f2","year":"1999","unstructured":"Szab\u00f2 I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, et al. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. Embo j. 1999;18(20):5517\u201327.","journal-title":"Embo j"},{"issue":"4","key":"404_CR89","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<453::AID-PATH950>3.0.CO;2-2","volume":"183","author":"V Ricci","year":"1997","unstructured":"Ricci V, Sommi P, Fiocca R, Romano M, Solcia E, Ventura U. Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia. J Pathol. 1997;183(4):453\u20139.","journal-title":"J Pathol"},{"issue":"3","key":"404_CR90","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0014-5793(01)03133-7","volume":"508","author":"L Morbiato","year":"2001","unstructured":"Morbiato L, Tombola F, Campello S, Del Giudice G, Rappuoli R, Zoratti M, et al. Vacuolation induced by VacA toxin of Helicobacter pylori requires the intracellular accumulation of membrane permeant bases, Cl(-) and water. FEBS Lett. 2001;508(3):479\u201383.","journal-title":"FEBS Lett"},{"issue":"7","key":"404_CR91","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1128\/IAI.66.7.3088-3094.1998","volume":"66","author":"MH Forsyth","year":"1998","unstructured":"Forsyth MH, Atherton JC, Blaser MJ, Cover TL. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains. Infect Immun. 1998;66(7):3088\u201394.","journal-title":"Infect Immun"},{"issue":"9","key":"404_CR92","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1128\/IAI.00500-07","volume":"75","author":"J Hisatsune","year":"2007","unstructured":"Hisatsune J, Yamasaki E, Nakayama M, Shirasaka D, Kurazono H, Katagata Y, et al. Helicobacter pylori VacA enhances prostaglandin E2 production through induction of cyclooxygenase 2 expression via a p38 mitogen-activated protein kinase\/activating transcription factor 2 cascade in AZ-521 cells. Infect Immun. 2007;75(9):4472\u201381.","journal-title":"Infect Immun"},{"key":"404_CR93","doi-asserted-by":"crossref","unstructured":"Bohush A, Niewiadomska G, Filipek A. Role of mitogen activated protein kinase signaling in Parkinson\u2019s disease. Int J Mol Sci 2018; 19(10).","DOI":"10.3390\/ijms19102973"},{"issue":"8","key":"404_CR94","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1074\/jbc.M308898200","volume":"279","author":"M Nakayama","year":"2004","unstructured":"Nakayama M, Kimura M, Wada A, Yahiro K, Ogushi K, Niidome T, et al. Helicobacter pylori VacA activates the p38\/activating transcription factor 2-mediated signal pathway in AZ-521 cells. J Biol Chem. 2004;279(8):7024\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"404_CR95","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1074\/jbc.M806981200","volume":"284","author":"M Nakayama","year":"2009","unstructured":"Nakayama M, Hisatsune J, Yamasaki E, Isomoto H, Kurazono H, Hatakeyama M, et al. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K\/Akt signaling pathway. J Biol Chem. 2009;284(3):1612\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"404_CR96","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI13045","volume":"108","author":"F Tombola","year":"2001","unstructured":"Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, Papini E. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest. 2001;108(6):929\u201337.","journal-title":"J Clin Invest"},{"issue":"3","key":"404_CR97","doi-asserted-by":"publisher","first-page":"e00609","DOI":"10.1128\/mBio.00609-12","volume":"4","author":"G Weiss","year":"2013","unstructured":"Weiss G, Forster S, Irving A, Tate M, Ferrero RL, Hertzog P, et al. Helicobacter pylori VacA suppresses Lactobacillus acidophilus-induced interferon beta signaling in macrophages via alterations in the endocytic pathway. mBio. 2013;4(3):e00609\u201300612.","journal-title":"mBio"},{"issue":"7","key":"404_CR98","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.4049\/jimmunol.180.7.5017","volume":"180","author":"J Hisatsune","year":"2008","unstructured":"Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, et al. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J Immunol. 2008;180(7):5017\u201327.","journal-title":"J Immunol"},{"issue":"5","key":"404_CR99","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1128\/IAI.72.5.2889-2898.2004","volume":"72","author":"RJ Menaker","year":"2004","unstructured":"Menaker RJ, Ceponis PJ, Jones NL. Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun. 2004;72(5):2889\u201398.","journal-title":"Infect Immun"},{"issue":"9","key":"404_CR100","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, et al. The role of small intestinal bacterial overgrowth in Parkinson\u2019s Disease. Mov Disord. 2013;28(9):1241\u20139.","journal-title":"Mov Disord"},{"issue":"21","key":"404_CR101","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.3390\/ijms222111663","volume":"22","author":"A D\u0103n\u0103u","year":"2021","unstructured":"D\u0103n\u0103u A, Dumitrescu L, Lefter A, Tulb\u0103 D, Popescu BO. Small intestinal bacterial overgrowth as potential therapeutic target in Parkinson\u2019s Disease. Int J Mol Sci. 2021;22(21):11663.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"404_CR102","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212\u201339.","journal-title":"Am J Gastroenterol"},{"issue":"1\u20132","key":"404_CR103","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clinbiochem.2016.08.017","volume":"50","author":"D Enko","year":"2017","unstructured":"Enko D, Kriegsh\u00e4user G. Functional (13)C-urea and glucose hydrogen\/methane breath tests reveal significant association of small intestinal bacterial overgrowth in individuals with active Helicobacter pylori Infection. Clin Biochem. 2017;50(1\u20132):46\u20139.","journal-title":"Clin Biochem"},{"key":"404_CR104","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-230X-11-146","volume":"11","author":"W Liu","year":"2011","unstructured":"Liu W, Chen Y, Lu G, Sun L, Si J. Down-regulation of HSP70 sensitizes gastric epithelial cells to apoptosis and growth retardation triggered by H. Pylori. BMC Gastroenterol. 2011;11:146.","journal-title":"BMC Gastroenterol"},{"issue":"21","key":"404_CR105","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.12998\/wjcc.v10.i21.7209","volume":"10","author":"M Dharan","year":"2022","unstructured":"Dharan M, Wozny D. Helicobacter pylori Infection and small intestinal bacterial overgrowth-more than what meets the eye. World J Clin Cases. 2022;10(21):7209\u201314.","journal-title":"World J Clin Cases"},{"issue":"3","key":"404_CR106","first-page":"213","volume":"13","author":"P Konrad","year":"2018","unstructured":"Konrad P, Chojnacki J, G\u0105siorowska A, Rudnicki C, Kaczka A, Chojnacki C. Therapeutic efficacy of Amoxicillin and Rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori Infection. Prz Gastroenterol. 2018;13(3):213\u20137.","journal-title":"Prz Gastroenterol"},{"key":"404_CR107","doi-asserted-by":"crossref","unstructured":"Pan I, Issac PK, Rahman MM, Guru A, Arockiaraj J. Gut-brain axis a key player to control gut dysbiosis in neurological Diseases. Mol Neurobiol 2023.","DOI":"10.1007\/s12035-023-03691-3"},{"issue":"1","key":"404_CR108","first-page":"58","volume":"1806","author":"AM Machado","year":"2010","unstructured":"Machado AM, Figueiredo C, Seruca R, Rasmussen LJ. Helicobacter pylori Infection generates genetic instability in gastric cells. Biochim Biophys Acta. 2010;1806(1):58\u201365.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"404_CR109","first-page":"23","volume":"60","author":"V Chiozzi","year":"2009","unstructured":"Chiozzi V, Mazzini G, Oldani A, Sciullo A, Ventura U, Romano M, et al. Relationship between Vac A toxin and ammonia in Helicobacter pylori-induced apoptosis in human gastric epithelial cells. Biochim Biophys Acta. 2009;60(3):23\u201330.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"404_CR110","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/biology8020038","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK. Mitochondrial dysfunction in Parkinson\u2019s disease-cause or consequence? Biology. 2019;8(2):38.","journal-title":"Biology"},{"key":"404_CR111","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ceb.2017.03.013","volume":"45","author":"TG McWilliams","year":"2017","unstructured":"McWilliams TG, Muqit MM. PINK1 and parkin: emerging themes in mitochondrial homeostasis. Curr Opin Cell Biol. 2017;45:83\u201391.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"404_CR112","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI108916","volume":"61","author":"R Wanitschke","year":"1978","unstructured":"Wanitschke R, Ammon HV. Effects of dihydroxy bile acids and hydroxy fatty acids on the absorption of oleic acid in the human jejunum. J Clin Invest. 1978;61(1):178\u201386.","journal-title":"J Clin Invest"},{"issue":"11","key":"404_CR113","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/j.1365-2036.2005.02493.x","volume":"21","author":"G Nucera","year":"2005","unstructured":"Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005;21(11):1391\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"404_CR114","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.autneu.2006.02.015","volume":"126\u2013127","author":"AE Lomax","year":"2006","unstructured":"Lomax AE, Linden DR, Mawe GM, Sharkey KA. Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Auton Neurosci. 2006;126\u2013127:250\u20137.","journal-title":"Auton Neurosci"},{"issue":"3","key":"404_CR115","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.mehy.2013.12.025","volume":"82","author":"J Kountouras","year":"2014","unstructured":"Kountouras J, Deretzi G, Gavalas E, Zavos C, Polyzos SA, Kazakos E, et al. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses. 2014;82(3):368\u201373.","journal-title":"Med Hypotheses"},{"issue":"7","key":"404_CR116","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/14740338.2023.2227096","volume":"22","author":"AM Richmond","year":"2023","unstructured":"Richmond AM, Lyons KE, Pahwa R. Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson\u2019s Disease. Expert Opin Drug Saf. 2023;22(7):563\u201379.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"404_CR117","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/cns.13994","volume":"29","author":"Q Si","year":"2023","unstructured":"Si Q, Gan C, Zhang H, Cao X, Sun H, Wang M, et al. Altered dynamic functional network connectivity in levodopa-induced dyskinesia of Parkinson\u2019s Disease. CNS Neurosci Ther. 2023;29(1):192\u2013201.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"404_CR118","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JPD-202298","volume":"11","author":"D Nyholm","year":"2021","unstructured":"Nyholm D, Hellstr\u00f6m PM. Effects of Helicobacter pylori on Levodopa Pharmacokinetics. J Parkinsons Dis. 2021;11(1):61\u20139.","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"404_CR119","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00415-021-10473-1","volume":"269","author":"R Zhong","year":"2022","unstructured":"Zhong R, Chen Q, Zhang X, Li M, Lin W. Helicobacter pylori Infection is associated with a poor response to levodopa in patients with Parkinson\u2019s Disease: a systematic review and meta-analysis. J Neurol. 2022;269(2):703\u201311.","journal-title":"J Neurol"},{"issue":"12","key":"404_CR120","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.22190","volume":"23","author":"WY Lee","year":"2008","unstructured":"Lee WY, Yoon WT, Shin HY, Jeon SH, Rhee PL. Helicobacter pylori Infection and motor fluctuations in patients with Parkinson\u2019s Disease. Mov Disord. 2008;23(12):1696\u2013700.","journal-title":"Mov Disord"},{"issue":"30","key":"404_CR121","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","volume":"20","author":"E Lahner","year":"2014","unstructured":"Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M. Helicobacter pylori Infection and Drugs malabsorption. World J Gastroenterol. 2014;20(30):10331\u20137.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"404_CR122","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1211\/jpp\/61.10.0005","volume":"61","author":"M Niehues","year":"2009","unstructured":"Niehues M, Hensel A. In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability? J Pharm Pharmacol. 2009;61(10):1303\u20137.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"404_CR123","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3892\/etm.2021.10095","volume":"22","author":"B Liu","year":"2021","unstructured":"Liu B, Dong J, Wang S, Yu H, Li Z, Sun P, et al. Helicobacter pylori causes delayed gastric emptying by decreasing interstitial cells of Cajal. Exp Ther Med. 2021;22(1):663.","journal-title":"Exp Ther Med"},{"issue":"1","key":"404_CR124","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2012.373","volume":"108","author":"M Camilleri","year":"2013","unstructured":"Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18\u201337. quiz 38.","journal-title":"Am J Gastroenterol"},{"key":"404_CR125","doi-asserted-by":"crossref","unstructured":"Yan S, Yue YZ, Wang XP, Dong HL, Zhen SG, Wu BS et al. Aqueous extracts of herba cistanche promoted intestinal motility in loperamide-induced constipation rats by ameliorating the interstitial cells of Cajal. Evid Based Complement Alternat Med 2017; 2017:6236904.","DOI":"10.1155\/2017\/6236904"},{"issue":"3","key":"404_CR126","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/db18-1064","volume":"68","author":"PJ Blair","year":"2019","unstructured":"Blair PJ, Hwang SJ, Shonnard MC, Peri LE, Bayguinov Y, Sanders KM, et al. The role of prostaglandins in disrupted gastric motor activity associated with type 2 Diabetes. Diabetes. 2019;68(3):637\u201347.","journal-title":"Diabetes"},{"issue":"5","key":"404_CR127","doi-asserted-by":"publisher","first-page":"BSR20170776","DOI":"10.1042\/BSR20170776","volume":"37","author":"S Yang","year":"2017","unstructured":"Yang S, Wu B, Sun H, Sun T, Han K, Li D, et al. Impaired insulin\/IGF-1 is responsible for diabetic gastroparesis by damaging myenteric cholinergic neurones and interstitial cells of Cajal. Biosci Rep. 2017;37(5):BSR20170776.","journal-title":"Biosci Rep"},{"key":"404_CR128","doi-asserted-by":"crossref","unstructured":"Zhao J, An J, Liu S. Electroacupuncture at ST36 increases bone marrow-derived interstitial cells of Cajal via the SDF-1\/CXCR4 and mSCF\/Kit-ETV1 pathways in the stomach of diabetic mice. Evid Based Complement Alternat Med 2018; 2018:7878053.","DOI":"10.1155\/2018\/7878053"},{"issue":"1","key":"404_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-5996-5-12","volume":"5","author":"QH Jin","year":"2013","unstructured":"Jin QH, Shen HX, Wang H, Shou QY, Liu Q. Curcumin improves expression of SCF\/c-kit through attenuating oxidative stress and NF-\u03baB activation in gastric tissues of diabetic gastroparesis rats. Diabetol Metab Syndr. 2013;5(1):12.","journal-title":"Diabetol Metab Syndr"},{"issue":"10","key":"404_CR130","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/ijms18102059","volume":"18","author":"J Zhou","year":"2017","unstructured":"Zhou J, O\u2019Connor MD, Ho V. The potential for gut organoid derived interstitial cells of Cajal in replacement therapy. Int J Mol Sci. 2017;18(10):2059.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"404_CR131","first-page":"4099","volume":"7","author":"YY Tan","year":"2014","unstructured":"Tan YY, Ji ZL, Zhao G, Jiang JR, Wang D, Wang JM. Decreased SCF\/c-kit signaling pathway contributes to loss of interstitial cells of Cajal in gallstone Disease. Int J Clin Exp Med. 2014;7(11):4099\u2013106.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"404_CR132","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tim.2022.11.006","volume":"31","author":"J Gao","year":"2023","unstructured":"Gao J, Wang Q, Tang YD, Zhai J, Hu W, Zheng C. When ferroptosis meets pathogenic Infections. Trends Microbiol. 2023;31(5):468\u201379.","journal-title":"Trends Microbiol"},{"issue":"2","key":"404_CR133","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3892\/mmr.2017.6749","volume":"16","author":"J Feng","year":"2017","unstructured":"Feng J, Gao J, Zhou S, Liu Y, Zhong Y, Shu Y, et al. Role of stem cell factor in the regulation of ICC proliferation and detrusor contraction in rats with an underactive bladder. Mol Med Rep. 2017;16(2):1516\u201322.","journal-title":"Mol Med Rep"},{"issue":"2","key":"404_CR134","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/gut.2005.071779","volume":"55","author":"EM El-Omar","year":"2006","unstructured":"El-Omar EM. Mechanisms of increased acid secretion after eradication of Helicobacter pylori Infection. Gut. 2006;55(2):144\u20136.","journal-title":"Gut"},{"issue":"7","key":"404_CR135","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.dld.2008.02.031","volume":"40","author":"D McNamara","year":"2008","unstructured":"McNamara D, El-Omar E. Helicobacter pylori Infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis. 2008;40(7):504\u20139.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"404_CR136","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.mehy.2009.11.001","volume":"74","author":"M Lyte","year":"2010","unstructured":"Lyte M. Microbial endocrinology as a basis for improved L-DOPA bioavailability in Parkinson\u2019s patients treated for Helicobacter pylori. Med Hypotheses. 2010;74(5):895\u20137.","journal-title":"Med Hypotheses"},{"issue":"3","key":"404_CR137","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1523-5378.2009.00682.x","volume":"14","author":"NC Doherty","year":"2009","unstructured":"Doherty NC, Tobias A, Watson S, Atherton JC. The effect of the human gut-signalling hormone, norepinephrine, on the growth of the gastric pathogen Helicobacter pylori. Helicobacter. 2009;14(3):223\u201330.","journal-title":"Helicobacter"},{"key":"404_CR138","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2020.05.001","volume":"76","author":"RF Pfeiffer","year":"2020","unstructured":"Pfeiffer RF, Isaacson SH, Pahwa R. Clinical implications of gastric Complications on levodopa treatment in Parkinson\u2019s Disease. Parkinsonism Relat Disord. 2020;76:63\u201371.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2\u20133","key":"404_CR139","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D Fotiadis","year":"2013","unstructured":"Fotiadis D, Kanai Y, Palac\u00edn M. The SLC3 and SLC7 families of amino acid transporters. Mol Aspects Med. 2013;34(2\u20133):139\u201358.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"404_CR140","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2009.08.020","volume":"289","author":"WH Jost","year":"2010","unstructured":"Jost WH. Gastrointestinal dysfunction in Parkinson\u2019s Disease. J Neurolo Sci. 2010;289(1):69\u201373.","journal-title":"J Neurolo Sci"}],"container-title":["Immunity &amp; Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-023-00404-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-023-00404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T11:17:06Z","timestamp":1704194226000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-023-00404-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1186\/s12979-023-00404-1","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"16 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}